Market Cap

Gentian Diagnostics AS Market Capitalization:

kr863.7 Million

NOK as of July 1, 2024

US$81.0 Million

business Gentian Diagnostics AS Company Profile

Gentian Diagnostics AS Main Stock Listing

OSE: GENT

Market Capitalization History of Gentian Diagnostics AS

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $204.45 B
Danaher $177.21 B
Siemens Healthineers AG $63.84 B
DexCom, Inc. $45.21 B
Lonza Group Ltd $39.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Gentian Diagnostics AS market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr632.3 M 2.24%
Jan. 1, 2023 kr618.4 M -42.45%
Jan. 1, 2022 kr1.07 B 25.52%
Jan. 1, 2021 kr856.1 M -1.69%
Jan. 1, 2020 kr870.8 M 5.36%
Jan. 1, 2019 kr826.6 M 33.33%
Jan. 1, 2018 kr619.9 M -2.33%
Jan. 1, 2017 kr634.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Gentian Diagnostics AS Categories

languages Healthcare languages Diagnostics & Research

Stocks & Indices

Gentian Diagnostics AS has the following listings and related stock indices.


Stock: OSE: GENT

Stock: FSX: 6FK

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.